Amicus Therapeutics, Inc. (0HF9.L)
USD 9.86
(-1.0%)
USD 9.86
(-1.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.51 USD | 37.8% |
| 2022 | -0.82 USD | 10.87% |
| 2021 | -0.92 USD | 14.02% |
| 2020 | -1.07 USD | 27.7% |
| 2019 | -1.48 USD | 21.28% |
| 2018 | -1.88 USD | -1.62% |
| 2017 | -1.85 USD | -24.16% |
| 2016 | -1.49 USD | -24.17% |
| 2015 | -1.20 USD | -29.03% |
| 2014 | -0.93 USD | 19.83% |
| 2013 | -1.16 USD | -8.41% |
| 2012 | -1.07 USD | 16.41% |
| 2011 | -1.28 USD | 35.35% |
| 2010 | -1.98 USD | -582.76% |
| 2009 | -0.29 USD | 83.43% |
| 2008 | -1.75 USD | 43.73% |
| 2007 | -3.11 USD | 95.06% |
| 2006 | -62.97 USD | -29.33% |
| 2005 | -48.69 USD | -70.01% |
| 2004 | -28.64 USD | -30.12% |
| 2003 | -22.01 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.05 USD | 67.69% |
| 2024 Q1 | -0.16 USD | -33.33% |
| 2023 Q4 | -0.12 USD | -64.38% |
| 2023 Q1 | -0.18 USD | 10.0% |
| 2023 FY | - USD | 37.8% |
| 2023 Q2 | -0.15 USD | 16.67% |
| 2023 Q3 | -0.07 USD | 51.33% |
| 2022 Q4 | -0.20 USD | -66.67% |
| 2022 FY | - USD | 10.87% |
| 2022 Q1 | -0.30 USD | 3.23% |
| 2022 Q2 | -0.21 USD | 30.0% |
| 2022 Q3 | -0.12 USD | 42.86% |
| 2021 Q2 | -0.19 USD | 24.0% |
| 2021 Q4 | -0.31 USD | -63.16% |
| 2021 FY | - USD | 14.02% |
| 2021 Q1 | -0.25 USD | 10.71% |
| 2021 Q3 | -0.19 USD | 0.0% |
| 2020 Q3 | -0.25 USD | -25.0% |
| 2020 Q1 | -0.35 USD | 0.0% |
| 2020 Q2 | -0.20 USD | 42.86% |
| 2020 FY | - USD | 27.7% |
| 2020 Q4 | -0.28 USD | -12.0% |
| 2019 Q2 | -0.36 USD | 35.71% |
| 2019 Q4 | -0.35 USD | -45.83% |
| 2019 Q3 | -0.24 USD | 33.33% |
| 2019 Q1 | -0.56 USD | -51.35% |
| 2019 FY | - USD | 21.28% |
| 2018 Q2 | -0.33 USD | -17.86% |
| 2018 Q4 | -0.37 USD | 55.95% |
| 2018 FY | - USD | -1.62% |
| 2018 Q1 | -0.28 USD | 34.88% |
| 2018 Q3 | -0.84 USD | -154.55% |
| 2017 Q1 | -0.39 USD | 11.36% |
| 2017 FY | - USD | -24.16% |
| 2017 Q4 | -0.43 USD | 37.68% |
| 2017 Q3 | -0.69 USD | -102.94% |
| 2017 Q2 | -0.34 USD | 12.82% |
| 2016 Q2 | -0.40 USD | -14.29% |
| 2016 FY | - USD | -24.17% |
| 2016 Q4 | -0.44 USD | -33.33% |
| 2016 Q3 | -0.33 USD | 17.5% |
| 2016 Q1 | -0.35 USD | -2.94% |
| 2015 FY | - USD | -29.03% |
| 2015 Q4 | -0.34 USD | -6.25% |
| 2015 Q3 | -0.32 USD | -18.52% |
| 2015 Q2 | -0.27 USD | -8.0% |
| 2015 Q1 | -0.25 USD | -4.17% |
| 2014 Q2 | -0.22 USD | 12.0% |
| 2014 Q3 | -0.22 USD | 0.0% |
| 2014 Q1 | -0.25 USD | -31.58% |
| 2014 FY | - USD | 19.83% |
| 2014 Q4 | -0.24 USD | -9.09% |
| 2013 Q2 | -0.31 USD | 11.43% |
| 2013 Q4 | -0.19 USD | 34.48% |
| 2013 Q1 | -0.35 USD | -75.0% |
| 2013 Q3 | -0.29 USD | 6.45% |
| 2013 FY | - USD | -8.41% |
| 2012 Q2 | -0.20 USD | 42.86% |
| 2012 Q4 | -0.20 USD | 41.18% |
| 2012 Q3 | -0.34 USD | -70.0% |
| 2012 Q1 | -0.35 USD | -52.17% |
| 2012 FY | - USD | 16.41% |
| 2011 Q4 | -0.23 USD | 17.86% |
| 2011 Q3 | -0.28 USD | 24.32% |
| 2011 Q1 | -0.39 USD | 11.36% |
| 2011 Q2 | -0.37 USD | 5.13% |
| 2011 FY | - USD | 35.35% |
| 2010 Q4 | -0.44 USD | 21.43% |
| 2010 FY | - USD | -582.76% |
| 2010 Q3 | -0.56 USD | -36.59% |
| 2010 Q2 | -0.41 USD | 24.07% |
| 2010 Q1 | -0.54 USD | -139.71% |
| 2009 FY | - USD | 83.43% |
| 2009 Q4 | 1.36 USD | 330.51% |
| 2009 Q3 | -0.59 USD | 1.67% |
| 2009 Q2 | -0.60 USD | -9.09% |
| 2009 Q1 | -0.55 USD | 12.7% |
| 2008 Q1 | -0.34 USD | 35.85% |
| 2008 FY | - USD | 43.73% |
| 2008 Q3 | -0.36 USD | 12.2% |
| 2008 Q2 | -0.41 USD | -20.59% |
| 2008 Q4 | -0.63 USD | -75.0% |
| 2007 Q3 | -0.46 USD | 65.41% |
| 2007 Q1 | -10.16 USD | 35.45% |
| 2007 Q4 | -0.53 USD | -15.22% |
| 2007 FY | - USD | 95.06% |
| 2007 Q2 | -1.33 USD | 86.91% |
| 2006 FY | - USD | -29.33% |
| 2006 Q2 | -15.74 USD | 0.0% |
| 2006 Q1 | -15.74 USD | -29.33% |
| 2006 Q4 | -15.74 USD | 0.0% |
| 2006 Q3 | -15.74 USD | 0.0% |
| 2005 Q1 | -12.17 USD | 0.0% |
| 2005 Q3 | -12.17 USD | 0.0% |
| 2005 Q2 | -12.17 USD | 0.0% |
| 2005 Q4 | -12.17 USD | 0.0% |
| 2005 FY | - USD | -70.01% |
| 2004 FY | - USD | -30.12% |
| 2003 FY | - USD | 0.0% |